Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Recombinant Protein Expression. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106906192A reveals high-efficiency microbial glucosyltransferase for crocetin ester synthesis. Offers superior yield and supply chain stability for pharmaceutical intermediates.
Patent CN1761742A reveals recombinant lactonase technology for efficient D-pantolactone synthesis, offering cost reduction and supply stability for vitamin B5 manufacturers.
Patent CN105002234B reveals enzymatic cAMP synthesis. Offers high purity, cost reduction, and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.